XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Additional Information (Details)
$ in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 11, 2022
shares
Dec. 31, 2021
shares
Jun. 30, 2022
USD ($)
plan
shares
Dec. 31, 2019
shares
Dec. 31, 2018
shares
Dec. 31, 2017
shares
Dec. 31, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Equity compensation plan, number of plans | plan     3        
Additional awards granted (in shares)     803,512        
Weighted-average remaining vesting period     2 years 4 months 24 days        
Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense | $     $ 15.3        
Non-vested restricted stock awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense related to unvested awards | $     $ 9.1        
Weighted-average of remaining vesting period     2 years 7 months 6 days        
Granted (in shares)     385,866        
Non-vested restricted stock awards | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based awards, vesting period     1 year        
Non-vested restricted stock awards | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based awards, vesting period     4 years        
Restricted Stock With Non-Market Performance Conditions              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)     218,418     98,817  
Restricted Stock Units (RSUs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense related to unvested awards | $     $ 2.7        
Weighted-average of remaining vesting period     2 years 7 months 6 days        
Granted (in shares)     2,571        
Unvested Performance Stock Awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense related to unvested awards | $     $ 1.7        
2005 Aerie Pharmaceutical Stock Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional awards granted (in shares)     0        
2013 Omnibus incentive plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional shares authorized (in shares)         4,500,000    
Number of shares authorized (in shares)   10,229,068          
Inducement Award Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional shares authorized (in shares)       100,000   874,500  
Number of shares authorized (in shares) 4,092,500           418,000
Inducement Award Plan | Chief Executive Officer              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)   602,952          
Amended And Restated Omnibus Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional shares authorized (in shares) 2,097,048